Export

Ethionamide
Essential medicine status
Section:
6. Anti-infective medicines 6.2. Antibacterials 6.2.5. Antituberculosis medicines
ATC codes: J04AD03
EMLc
Indication
Tuberculous meningitis ICD11 code: 1B11.0
INN
Ethionamide
Medicine type
Chemical agent
List type
Core
Formulations
Oral > Solid: 250 mg tablet ; 125 mg tablet (dispersible)
EML status history
First added in 2023 (TRS 1049)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Wikipedia
Ethionamide
DrugBank
Ethionamide
Summary of evidence and Expert Committee recommendations
The Expert Committee recommended the inclusion of ethionamide on the core list of the EML and EMLc for the new indication for treatment of drug-susceptible tuberculosis meningitis in children and adolescents, as part of a 6-month intensive regimen in combination with isoniazid, rifampicin and pyrazinamide.